Search Results - "Artis, Dean R."
-
1
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF -mutant melanoma
Published in Nature (London) (30-09-2010)“…B-RAF is the most frequently mutated protein kinase in human cancers. The finding that oncogenic mutations in BRAF are common in melanoma, followed by the…”
Get full text
Journal Article -
2
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor
Published in Proceedings of the National Academy of Sciences - PNAS (02-04-2013)“…Inflammation and cancer, two therapeutic areas historically addressed by separate drug discovery efforts, are now coupled in treatment approaches by a growing…”
Get full text
Journal Article -
3
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
Published in Proceedings of the National Academy of Sciences - PNAS (06-01-2009)“…In a search for more effective anti-diabetic treatment, we used a process coupling low-affinity biochemical screening with high-throughput co-crystallography…”
Get full text
Journal Article -
4
Crystal Structures of Proto-oncogene Kinase Pim1: A Target of Aberrant Somatic Hypermutations in Diffuse Large Cell Lymphoma
Published in Journal of molecular biology (22-04-2005)“…Pim1, a serine/threonine kinase, is involved in several biological functions including cell survival, proliferation, and differentiation. While pim1 has been…”
Get full text
Journal Article -
5
Comprehensive and Quantitative Mapping of Energy Landscapes for Protein-Protein Interactions by Rapid Combinatorial Scanning
Published in The Journal of biological chemistry (04-08-2006)“…A novel, quantitative saturation (QS) scanning strategy was developed to obtain a comprehensive data base of the structural and functional effects of all…”
Get full text
Journal Article -
6
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design
Published in Nature biotechnology (01-02-2005)“…Cyclic nucleotide phosphodiesterases (PDEs) comprise a large family of enzymes that regulate a variety of cellular processes. We describe a family of potent…”
Get full text
Journal Article -
7
Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors
Published in Bioorganic & medicinal chemistry letters (15-05-2013)“…Utilizing a structure based design approach, combined with extensive medicinal chemistry execution, highly selective, potent and novel BACE1 inhibitor 8 (BACE1…”
Get full text
Journal Article -
8
Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors
Published in Bioorganic & medicinal chemistry letters (01-05-2013)“…Polo-like kinase-2 (Plk-2) is a potential therapeutic target for Parkinson’s disease and this Letter describes the SAR of a series of dihydropteridinone based…”
Get full text
Journal Article -
9
Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor
Published in Bioorganic & medicinal chemistry letters (15-03-2011)“…The SAR of a series of tri-substituted thiophene JNK3 inhibitors is described. By optimizing both the N-aryl acetamide region of the inhibitor and the…”
Get full text
Journal Article -
10
Including Explicit Water Molecules as Part of the Protein Structure in MM/PBSA Calculations
Published in Journal of chemical information and modeling (24-02-2014)“…Water is the natural medium of molecules in the cell and plays an important role in protein structure, function and interaction with small molecule ligands…”
Get full text
Journal Article -
11
Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase with Potent Antimelanoma Activity
Published in Proceedings of the National Academy of Sciences - PNAS (26-02-2008)“…$BRAF^{V600E}$ is the most frequent oncogenic protein kinase mutation known. Furthermore, inhibitors targeting "active" protein kinases have demonstrated…”
Get full text
Journal Article -
12
A Selective, Slow Binding Inhibitor of Factor VIIa Binds to a Nonstandard Active Site Conformation and Attenuates Thrombus Formation in Vivo
Published in The Journal of biological chemistry (11-03-2005)“…The serine protease factor VIIa (FVIIa) in complex with its cellular cofactor tissue factor (TF) initiates the blood coagulation reactions. TF·FVIIa is also…”
Get full text
Journal Article -
13
Conformations of Thioamide-Containing Dipeptides: A Computational Study
Published in Journal of the American Chemical Society (02-12-1998)“…Four model dipeptides, Ac-ψ[CSNH]-Gly-NHMe, Ac-Gly-ψ[CSNH]-NHMe, Ac-ψ[CSNH]-Ala-NHMe, and Ac-Ala-ψ[CSNH]-NHMe, each containing a thioamide bond, were studied…”
Get full text
Journal Article -
14
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
Published in Structure (London) (01-12-2004)“…Phosphodiesterases (PDEs) comprise a large family of enzymes that catalyze the hydrolysis of cAMP or cGMP and are implicated in various diseases. We describe…”
Get full text
Journal Article -
15
Oxidative Radical Cyclization of (.omega.-Iodoalkyl)indoles and Pyrroles. Synthesis of (-)-Monomorine and Three Diastereomers
Published in Journal of organic chemistry (01-05-1994)Get full text
Journal Article -
16
Thermodynamic and kinetic characterization of hydroxyethylamine β-secretase-1 inhibitors
Published in Biochemical and biophysical research communications (15-11-2013)“…•Kinetic and thermodynamic characterization of 10 hydroxyethylamine BACE-1 inhibitors.•Equilibrium binding of inhibitors was enthalpy driven for…”
Get full text
Journal Article -
17
Selective and Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors That Reduce [alpha]-Synuclein Phosphorylation in Rat Brain
Published in ChemMedChem (01-08-2013)“…Polo-like kinase-2 (Plk-2) has been implicated as the dominant kinase involved in the phosphorylation of [alpha]-synuclein in Lewy bodies, which are one of the…”
Get full text
Journal Article -
18
Selective and Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors That Reduce α-Synuclein Phosphorylation in Rat Brain
Published in ChemMedChem (01-08-2013)“…Polo‐like kinase‐2 (Plk‐2) has been implicated as the dominant kinase involved in the phosphorylation of α‐synuclein in Lewy bodies, which are one of the…”
Get full text
Journal Article -
19
Label free fragment screening using surface plasmon resonance as a tool for fragment finding - analyzing parkin, a difficult CNS target
Published in PloS one (05-07-2013)“…Surface Plasmon Resonance (SPR) is rarely used as a primary High-throughput Screening (HTS) tool in fragment-based approaches. With SPR instruments becoming…”
Get full text
Journal Article -
20
Correction: Label Free Fragment Screening Using Surface Plasmon Resonance as a Tool for Fragment Finding – Analyzing Parkin, a Difficult CNS Target
Published in PloS one (30-07-2013)Get full text
Journal Article